CLINICAL_TRIALS
research
· 2021-05-18
Clinical Trial Update: Pharmacogenomics of Thiazolidinediones [NA]
Summary
Pharmacogenomics-focused clinical trial update on thiazolidinediones in type 2 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2021-05-18